Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

TTEK vs BMI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TTEK Captures Overall Composite Edge (45.1 HOLD vs 49.8 HOLD), While BMI Leads 4–2 on Growth & Valuation Pillars

TTEK Overall Winner 6-Pillar Tally: TTEK 2 – 4 BMI Matrix Metrics: TTEK 6 – 4 BMI

As of Nov 20, 2026, Tetra Tech Inc (TTEK) captures the overall head-to-head institutional edge over Badger Meter, Inc. (BMI) on higher Unified Composite conviction (45.1/100 HOLD vs. 49.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Growth & Scale), while BMI wins 4–2 across the 6-pillar growth and valuation breakdown. TTEK trades at $36.95 (21.6x Forward P/E, 14.0% operating margin) versus BMI at $154.27 (30.9x Forward P/E, 18.8% operating margin).

  • Composite vs. Pillar Nuance: While BMI currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. TTEK 45.1/100 HOLD), TTEK captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (14.0% vs. 18.8% operating margin) and revenue trajectory (-0.9% vs. +0.1% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TTEK vs BMI
TTEK NASDAQ Head-to-Head Winner
Tetra Tech Inc
Services-Engineering Services
$36.95
-0.94% 1D
Market Cap $9.4B
TTM Revenue $4.35B
Forward P/E 21.6x
Beta / 30D Vol 0.25β · 40% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 20.0 Fund 44.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 45.7 · SMA20: $38.79 · SMA50: $36.27
BMI NYSE
Badger Meter, Inc.
Totalizing Fluid Meters & Counting Devices
$154.27
-0.17% 1D
Market Cap $4.5B
TTM Revenue $881M
Forward P/E 30.9x
Beta / 30D Vol 0.46β · 51% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 34.0 Fund 47.0 Flow 56.0 Mom 56.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 55
RSI-14: 55.3 · SMA20: $155.17 · SMA50: $139.98

6-Pillar Scorecard Institutional Category Breakdown (TTEK 2 – 4 BMI)

Columns: Metric · TTEK · BMI
1. Valuation Multiples TTEK
Forward P/E 21.6x 30.9x
Trailing P/E 22.1x 35.7x
PEG Ratio 2.10x 3.68x
EV / Revenue 2.2x 5.1x
2. Growth & Scale TTEK
Revenue Growth (YoY) -0.9% +0.1%
Earnings Growth (YoY) +5.8% +4.2%
TTM Revenue (USD) $4.35B $881M
Market Cap $9.4B $4.5B
3. Profitability & Quality BMI
Gross Margin 21.7% 41.6%
Operating Margin 14.0% 18.8%
Net Profit Margin 10.1% 14.4%
Return on Equity (ROE) 24.1% 18.7%
4. Balance Sheet & Cash Flow BMI
Cash Generation (TTM) $663M EBITDA $142M
Cash Flow Margin 15.3% EBITDA Mgn 16.2%
Net Cash / Leverage $7.44 Book/Sh · 24.1% ROE $22.80 Book/Sh · 18.7% ROE
Dividend Yield 0.72% 1.05%
5. Options & Positioning BMI
Options Structure Phase CONSOLIDATION SURGE
Current IV / %ile 34.1% (19th %ile) 40.4% (7th %ile)
Put/Call OI Skew 0.06x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat BMI
OpEx & R&D Intensity 7.7% of Rev ($335M) 22.8% of Rev ($201M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Engineering & Construction Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TTEK (6) vs BMI (4)
Institutional Metric TTEK BMI Criterion Row Edge
Market Capitalization
Scale
$9.4B $4.5B Larger Scale TTEK
Trailing P/E Ratio
Valuation
22.1x 35.7x Lower Multiple TTEK
Forward P/E Ratio
Valuation
21.6x 30.9x Lower Multiple TTEK
Revenue Growth (YoY)
Growth
-0.9% +0.1% Higher Growth BMI
Operating Margin (TTM)
Profitability
14.0% 18.8% Higher Margin BMI
Net Profit Margin
Profitability
10.1% 14.4% Higher Margin BMI
Return on Equity (ROE)
Capital Efficiency
24.1% 18.7% Higher ROE TTEK
52-Week Range Position
Momentum
64% ($26–$43) 56% ($112–$187) Stronger Trend TTEK
Beta / 30D Volatility
Risk Regime
0.25β · 40% Vol 0.46β · 51% Vol Lower Realized Risk TTEK
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 49.8 / 100 (HOLD) Higher Composite BMI
Trailing 12M Revenue (USD)
Operating Scale
$4.35B $881M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
21.7% 41.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.10x PEG · 2.2x EV/Rev 3.68x PEG · 5.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$663M EBITDA ($7.44 Book/Sh · 24.1% ROE) $142M ($22.80 Book/Sh · 18.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BMI +2.71 pp
TTEK: +0.38% · BMI: +3.09%
3M Horizon BMI +13.36 pp
TTEK: +0.24% · BMI: +13.6%
6M Horizon TTEK +11.04 pp
TTEK: +33.63% · BMI: +22.59%
1Y Horizon TTEK +13.27 pp
TTEK: +4.53% · BMI: -8.74%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period TTEK Revenue BMI Revenue TTEK Op. Margin BMI Op. Margin Margin Leader
FY2018 $2.96B $430M 6.4% 13.1% BMI
FY2019 $3.11B $420M 6.1% 14.6% BMI
FY2020 $2.99B $430M 8.1% 15.3% BMI
FY2021 $3.21B $510M 8.7% 15.6% BMI
FY2022 $3.50B $570M 9.7% 15.4% BMI
FY2023 $4.52B $700M 7.9% 16.8% BMI
FY2024 $5.20B $830M 9.6% 19.1% BMI
FY2025 $5.44B $920M 7.5% 20.0% BMI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TTEK CONSOLIDATION
64d in phase · OBV DISTRIBUTION
Current IV 34.1%
IV Percentile 19th %ile
Put/Call OI Skew 0.06x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact TTEK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMI SURGE
12d in phase · OBV NEUTRAL
Current IV 40.4%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact BMI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TTEK Moat Profile Scale & Operating Efficiency Moat
Engineering & Construction Operator
Competes within the Engineering & Construction value chain with $9.4B market capitalization and 14.0% operating margin.
OpEx & R&D Reinvestment 7.7% of Rev ($335M)
90D Engineering Disclosures 0 Published
BMI Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $4.5B market capitalization and 18.8% operating margin.
OpEx & R&D Reinvestment 22.8% of Rev ($201M)
90D Engineering Disclosures 0 Published

Investor FAQ TTEK vs BMI Key Questions & Quantitative Answers

As of Nov 20, 2026, Tetra Tech Inc (TTEK) captures the overall head-to-head institutional edge over Badger Meter, Inc. (BMI) on higher Unified Composite conviction (45.1/100 HOLD vs. 49.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Growth & Scale), while BMI wins 4–2 across the 6-pillar growth and valuation breakdown. TTEK trades at $36.95 (21.6x Forward P/E, 14.0% operating margin) versus BMI at $154.27 (30.9x Forward P/E, 18.8% operating margin). Composite vs. Pillar Nuance: While BMI currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. TTEK 45.1/100 HOLD), TTEK captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (14.0% vs. 18.8% operating margin) and revenue trajectory (-0.9% vs. +0.1% YoY).

TTEK leads the Growth & Scale pillar: TTEK posts -0.9% YoY revenue growth and +5.8% YoY earnings growth on $4.35B TTM revenue (21.7% gross margin, 14.0% operating margin), compared with BMI at +0.1% YoY revenue growth and +4.2% YoY earnings growth on $881M TTM revenue (41.6% gross margin, 18.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), TTEK cumulative revenue shifted +83.8% while BMI shifted +114.0%. In operating R&D and SG&A reinvestment, TTEK deploys 7.7% of Rev ($335M) (0 90-day corporate R&D disclosures) versus 22.8% of Rev ($201M) (0 disclosures) for BMI.

TTEK screens cheaper on headline valuation multiples. TTEK trades at 21.6x Forward P/E, 22.1x Trailing P/E, 2.10x PEG, and 2.2x EV/Revenue (15.3% EBITDA margin), whereas BMI trades at 30.9x Forward P/E, 35.7x Trailing P/E, 3.68x PEG, and 5.1x EV/Revenue (16.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TTEK (24.1% ROE) versus BMI (18.7% ROE) capital efficiency.

In options market volatility and institutional positioning, TTEK carries 34.1% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.06x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.25β · 40% Vol realized risk). By comparison, BMI carries 40.4% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.46β · 51% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.